Subcutaneous versus intravenous erythropoietin for long-term dialysis patients

Author:

Gupta Ashwani K1,Anand Vidhu2,Narula Sumit1

Affiliation:

1. University of Florida-Jacksonville; Nephrology; 655 W 8th Street Jacksonville FL USA 32209

2. University of Minnesota; Department of Medicine; 420 Delaware Street SE Mayo Mail Code 195 Minneapolis MN USA 55455

Publisher

Wiley

Subject

Pharmacology (medical)

Reference19 articles.

1. Pure red-cell aplasia and epoetin therapy;Bennett;New England Journal of Medicine,2004

2. Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: the case for subcutaneous administration;Besarab;Journal of the American Society of Nephrology,1992

3. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin;Casadevall;New England Journal of Medicine,2002

4. Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease;Deicher;Drugs,2004

5. Anemia of end-stage renal disease (ESRD);Eschbach;Kidney International,1985

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3